v3.26.1
STOCKHOLDERS’ EQUITY
3 Months Ended
Jun. 30, 2026
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS’ EQUITY Stockholders’ Equity
Stock Repurchase Program (amounts in thousands, except share and per share data). The Company’s Board of
Directors (Board) has approved a stock repurchase program which authorizes the Company to repurchase shares
of its common stock in the open market or in privately negotiated transactions, subject to market conditions,
applicable legal requirements, and other factors (collectively, the stock repurchase program). The Board last
approved an additional authorization of $3,500,000 on May 20, 2026, to repurchase shares of the Company’s
common stock under the same conditions as the prior stock repurchase program. As of June 30, 2026, the
aggregate remaining authorization under the stock repurchase program is $4,711,416.
The stock repurchase program does not obligate the Company to acquire any amount of common stock and may be
suspended at any time at the Company’s discretion. The credit agreements governing the Company’s revolving
credit facilities allow it to make stock repurchases under this program, so long as it does not exceed certain
leverage ratios. As of June 30, 2026, the Company has not exceeded the stated leverage ratios, and no defaults
have occurred under these credit agreements.
Stock repurchase activity under the stock repurchase program was as follows:
Three Months Ended June 30,
2026
2025
Total number of shares repurchased (1)
3,258,352
1,665,902
Weighted average price per share
$103.79
$109.84
Dollar value of shares repurchased (2) (3)
$338,186
$182,991
(1) All share repurchases were made pursuant to the stock repurchase program in open-market transactions.
(2) May not calculate on rounded amounts.
(3) The dollar value of shares repurchased excludes the cost of broker commissions, excise taxes, and other costs.
Subsequent to June 30, 2026, through July 9, 2026, the Company repurchased 311,264 shares of its common stock
at a weighted average price of $103.35 per share for $32,168. As of July 9, 2026, the Company had $4,679,248
remaining authorized for repurchases under the stock repurchase program.
Accumulated Other Comprehensive Loss. The components within AOCL, net of tax, recorded in the condensed
consolidated balance sheets, are as follows:
 
June 30, 2026
March 31, 2026
Unrealized gain on cash flow hedges
$8,342
$5,564
Cumulative foreign currency translation loss
(40,974)
(41,483)
Total
$(32,632)
$(35,919)